Company Filing History:
Years Active: 2015
Title: Myra N Widjojoatmodjo: Innovator in Vaccine Development
Introduction
Myra N Widjojoatmodjo is a prominent inventor based in Leiden, Netherlands. She has made significant contributions to the field of vaccine development, particularly in combating respiratory syncytial virus (RSV). With a total of 2 patents, her work is vital in advancing public health.
Latest Patents
Myra's latest patents include a vaccine against RSV, which comprises a recombinant human adenovirus of serotype 26 that encodes a RSV F protein or an immunologically active part thereof. This innovative approach aims to provide effective protection against RSV, a virus that poses serious health risks, especially to infants and the elderly.
Career Highlights
Myra is associated with Crucell Holland B.V., a company known for its focus on vaccine development and biopharmaceuticals. Her work at Crucell has positioned her as a key player in the fight against infectious diseases.
Collaborations
Myra collaborates with notable colleagues, including Katarina Radosevic and Jerome H H V Custers. These partnerships enhance the research and development efforts within her field.
Conclusion
Myra N Widjojoatmodjo's contributions to vaccine innovation are commendable and play a crucial role in addressing public health challenges. Her dedication to developing effective vaccines against RSV showcases her commitment to improving health outcomes.